The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19,…

Keep Focus on Emerging Infections, Disease X: Analysts

Keep Focus on Emerging Infections, Disease X: Analysts

Research funding for emerging infectious diseases rarely reaches the countries where such diseases do the most harm, according to new data analysis that highlights how…

Attributes and Predictors of Long-COVID

Attributes and Predictors of Long-COVID

Long-COVID is characterized by symptoms of fatigue, headache, dyspnoea and anosmia. At the population level, it is critical to quantify the burden of Long-COVID to…

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers University of Minnesota Medical School physician researchers studied hydroxychloroquine as a…

Building an ACE2 Receptor Trap for Pandemic Pathogens

Building an ACE2 Receptor Trap for Pandemic Pathogens

Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II (ACE2) receptor traps which neutralize…

DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

Military units conduct reconnaissance missions to obtain information – by visual observation or other detection methods – about the activities and resources of an enemy.…

View All Featured News



HEADLINE NEWS

Biodefense Headlines – 21 July 2019

Biodefense Headlines – 21 July 2019

Contents POLICY + POLITICSHealth Security Threats are Real: What is Congress Doing?Mystery Surrounds Ouster of Chinese Researchers from Canadian LaboratoryNation Faces Long-Standing Challenges Related to…

Biodefense Headlines: Hospital Ebola Preparedness, Animal BSL-3 Labs, Uganda’s Select Agent Tracking Program

Biodefense Headlines: Hospital Ebola Preparedness, Animal BSL-3 Labs, Uganda’s Select Agent Tracking Program

See what we’re reading this week at Global Biodefense on topics including: biosafety considerations in Animal BSL-3 labs; transforming the Strategic National Stockpile; and U.S.…

Burden of Measles on Public Health, Infectious Disease Physician Shortage, Ebola IHR Emergency Committee Meeting

Burden of Measles on Public Health, Infectious Disease Physician Shortage, Ebola IHR Emergency Committee Meeting

See what we’re reading this week at Global Biodefense on topics including the state of Yersinia pestis diagnostics, how measles is testing the public health…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Free Coronavirus Sequencing Kits for Researchers Offered by U-M Startup

As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic…

BD, BioGX Announce FDA EUA Submissions for New COVID-19 Diagnostics

BD and BioGX Inc today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and Drug Administration (FDA) for new diagnostic tests…

Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients

U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and announced on Mar. 16…

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Coronavirus Vaccine

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the first participant has been dosed in the Phase 1…

CEPI Gets €140 Million Funding Boost From Germany While Expanding Coronavirus Vaccine Search

The German Government’s Federal Ministry of Education and Research announced on Mar. 11 an additional €140 million (US$157 million) to support the Coalition for Epidemic Preparedness Innovations’…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa